Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 2
1988 2
1989 2
1990 2
1992 3
1993 2
1995 4
1996 3
1997 3
1998 2
1999 4
2000 12
2001 7
2002 15
2003 15
2004 6
2005 15
2006 14
2007 11
2008 13
2009 24
2010 31
2011 25
2012 26
2013 41
2014 38
2015 47
2016 36
2017 52
2018 48
2019 54
2020 65
2021 83
2022 54
2023 62
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

716 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy.
Eftimov F, Lucke IM, Querol LA, Rajabally YA, Verhamme C. Eftimov F, et al. Brain. 2020 Dec 5;143(11):3214-3224. doi: 10.1093/brain/awaa265. Brain. 2020. PMID: 33155018 Free PMC article. Review.
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) consists of a spectrum of autoimmune diseases of the peripheral nerves, causing weakness and sensory symptoms. ...
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) consists of a spectrum of autoimmune diseases o …
Neuromuscular Diseases.
Morrison BM. Morrison BM. Semin Neurol. 2016 Oct;36(5):409-418. doi: 10.1055/s-0036-1586263. Epub 2016 Sep 23. Semin Neurol. 2016. PMID: 27704495 Review.
., axonal peripheral neuropathies or brachial plexopathies), Schwann cells (i.e., chronic inflammatory demyelinating polyradiculoneuropathy), neuromuscular junction (i.e., myasthenia gravis or Lambert-Eaton myasthenic syndrome), muscle (i.e., inflammat …
., axonal peripheral neuropathies or brachial plexopathies), Schwann cells (i.e., chronic inflammatory demyelinating …
Peripheral neuropathies.
Hanewinckel R, Ikram MA, Van Doorn PA. Hanewinckel R, et al. Handb Clin Neurol. 2016;138:263-82. doi: 10.1016/B978-0-12-802973-2.00015-X. Handb Clin Neurol. 2016. PMID: 27637963 Review.
Immune-mediated polyneuropathies like Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy are rare diseases, with an annual incidence of approximately 1-2 and 0.2-0.5 per 100 000 persons respectively. ...
Immune-mediated polyneuropathies like Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneu …
Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Querol L, Lleixà C. Querol L, et al. Neurotherapeutics. 2021 Oct;18(4):2222-2235. doi: 10.1007/s13311-021-01117-3. Epub 2021 Sep 21. Neurotherapeutics. 2021. PMID: 34549385 Free PMC article. Review.
Inflammatory neuropathies are a heterogeneous group of rare diseases of the peripheral nervous system that include acute and chronic diseases, such as Guillain-Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). . …
Inflammatory neuropathies are a heterogeneous group of rare diseases of the peripheral nervous system that include acute and chronic disease …
Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database.
Doneddu PE, Cocito D, Manganelli F, Fazio R, Briani C, Filosto M, Benedetti L, Mazzeo A, Marfia GA, Cortese A, Fierro B, Jann S, Beghi E, Clerici AM, Carpo M, Schenone A, Luigetti M, Lauria G, Antonini G, Rosso T, Siciliano G, Cavaletti G, Liberatore G, Santoro L, Peci E, Tronci S, Ruiz M, Cotti Piccinelli S, Toscano A, Mataluni G, Piccolo L, Cosentino G, Sabatelli M, Nobile-Orazio E; Italian CIDP Database study group. Doneddu PE, et al. J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):125-132. doi: 10.1136/jnnp-2018-318714. Epub 2018 Oct 8. J Neurol Neurosurg Psychiatry. 2019. PMID: 30297520 Free article.
OBJECTIVES: A few variants of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) have been described, but their frequency and evolution to typical CIDP remain unclear. ...
OBJECTIVES: A few variants of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) have been describ …
Peripherin is a biomarker of axonal damage in peripheral nervous system disease.
Keddie S, Smyth D, Keh RYS, Chou MKL, Grant D, Surana S, Heslegrave A, Zetterberg H, Wieske L, Michael M, Eftimov F, Bellanti R, Rinaldi S, Hart MS, Petzold A, Lunn MP. Keddie S, et al. Brain. 2023 Nov 2;146(11):4562-4573. doi: 10.1093/brain/awad234. Brain. 2023. PMID: 37435933 Free PMC article.
We examined longitudinal serum peripherin and NfL concentrations in individuals with Guillain-Barre syndrome (GBS, n = 45, 179 time points), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP, n = 35, 70 time points), multiple sclerosis (n …
We examined longitudinal serum peripherin and NfL concentrations in individuals with Guillain-Barre syndrome (GBS, n = 45, 179 time points), …
POEMS syndrome.
Keddie S, Lunn MP. Keddie S, et al. Curr Opin Neurol. 2018 Oct;31(5):551-558. doi: 10.1097/WCO.0000000000000610. Curr Opin Neurol. 2018. PMID: 30138145 Review.
SUMMARY: Understanding links between the monoclonal lambda plasma cell disorder and resulting proinflammatory cytokine milieu is fundamental to determining POEMS syndrome pathophysiology. Similarities to chronic inflammatory demyelinating polyradiculoneuro …
SUMMARY: Understanding links between the monoclonal lambda plasma cell disorder and resulting proinflammatory cytokine milieu is fundamental …
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial.
Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, Hartung HP, Latov N, Merkies IS, van Doorn PA; ICE Study Group. Hughes RA, et al. Lancet Neurol. 2008 Feb;7(2):136-44. doi: 10.1016/S1474-4422(07)70329-0. Lancet Neurol. 2008. PMID: 18178525 Clinical Trial.
BACKGROUND: Short-term studies suggest that intravenous immunoglobulin might reduce disability caused by chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) but long-term effects have not been shown. ...
BACKGROUND: Short-term studies suggest that intravenous immunoglobulin might reduce disability caused by chronic inflammatory …
Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
Adrichem ME, Lucke IM, Vrancken AFJE, Goedee HS, Wieske L, Dijkgraaf MGW, Voermans NC, Notermans NC, Faber CG, Visser LH, Kuitwaard K, van Doorn PA, Merkies ISJ, de Haan RJ, van Schaik IN, Eftimov F. Adrichem ME, et al. Brain. 2022 Jun 3;145(5):1641-1652. doi: 10.1093/brain/awac054. Brain. 2022. PMID: 35139161 Free PMC article. Clinical Trial.
Intravenous immunoglobulins are an efficacious treatment for chronic inflammatory demyelinating polyradiculoneuropathy. Biomarkers for disease activity are lacking, making the need for ongoing treatment difficult to assess, leading to potential overtre …
Intravenous immunoglobulins are an efficacious treatment for chronic inflammatory demyelinating polyradiculoneuropat …
716 results